You are going to a different site than you have been browsing. Click continue to visit site or close to select a site with our global language selector.
Make sure your keyword(s) are spelled correctly
Try another keyword(s)
Try more general keyword(s)
Technology for healthier lives
We understand that delivering quality diagnostic care with the lowest possible radiation dose is a desired goal. Learn how our Dose Management solutions can help you achieve Dose Leadership.
You've earned her trust. Keep it by being a dose management leader.
GoldSeal - Refurbished Systems
To help you maximize your investment dollars, GE will refurbish many of its product models and sells them at competitive prices.
Hospital & Healthcare Solutions
Hospital & Healthcare Solutions (HHS) is a team of experts with global experience and access to technology, services, financing and partners to bring your project to life.
The commitment made by GE to the European Commission.
Interoperability is the sharing of information between medical devices and information systems.
Upgrade your current equipment to expand your clinical capability, maximize your return on investment and streamline your workflow - at any time in the equipment lifecycle.
Offering by Product
DoseWatch - Dose Management Solution
GE Healthcare’s DoseWatch dose management solution can be the cornerstone of a comprehensive, proactive radiation management program.
Public & Private Partnerships in Healthcare
Working with governments and consortia of private healthcare providers and financiers to build infrastructure, services and capabilities.
News and Events
News and Events
United Kingdom and Ireland / English
Return to Global Selection Page
Share This Page
10-year fracture risk assessment from the World Health Organization, seamlessly integrated in GE DXA densitometry systems.
Our FRAX software application helps you identify which of your patients are more likely to suffer a hip fracture or a major osteoporotic fracture of the clinical spine, forearm, hip, or shoulder within the next 10 years. Using an algorithm developed by the
World Health Organization, it automatically incorporates the results from a
femoral bone mineral density (BMD) test,
while also considering risk factors. The FRAX model also helps you identify the subset of patients in the low bone mass category that would likely benefit most from treatment.
Compared to BMD T-scores alone, the use of 10-year fracture-probability assessments may provide a better basis for shared decision-making between patient and physician.
FRAX Brochure (PDF).
The FRAX model is useful in identifying the subset of patients in the low-bone-mass category most likely to benefit from treatment (those with a T-score of –1 to –2.5, categorized as having osteopenia). This is an important advance, since the majority of fractures do not occur in patients with osteoporosis.1
The FRAX model also includes men and different ethnicities, two groups experiencing an increase in osteoporotic fractures. However, osteoporosis testing and intervention have been largely neglected.2
In addition, FRAX helps you identify patients with co-morbid conditions that increase fracture risk, and targets them for intervention.3
Percentage of non-vertebral,
hip, upper humerus and wrist fractures that occurred in men and women with
osteoporosis, osteopenia or normal BMD using gender specific T-scores.4
See additional features in the latest enCORE software.